Literature DB >> 33480441

DNA topoisomerases: Advances in understanding of cellular roles and multi-protein complexes via structure-function analysis.

Shannon J McKie1,2, Keir C Neuman2, Anthony Maxwell1.   

Abstract

DNA topoisomerases, capable of manipulating DNA topology, are ubiquitous and indispensable for cellular survival due to the numerous roles they play during DNA metabolism. As we review here, current structural approaches have revealed unprecedented insights into the complex DNA-topoisomerase interaction and strand passage mechanism, helping to advance our understanding of their activities in vivo. This has been complemented by single-molecule techniques, which have facilitated the detailed dissection of the various topoisomerase reactions. Recent work has also revealed the importance of topoisomerase interactions with accessory proteins and other DNA-associated proteins, supporting the idea that they often function as part of multi-enzyme assemblies in vivo. In addition, novel topoisomerases have been identified and explored, such as topo VIII and Mini-A. These new findings are advancing our understanding of DNA-related processes and the vital functions topos fulfil, demonstrating their indispensability in virtually every aspect of DNA metabolism.
© 2021 The Authors. BioEssays published by Wiley Periodicals LLC. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  DNA gyrase; DNA supercoiling; DNA topoisomerase; anti-cancer drugs; antibiotics

Year:  2021        PMID: 33480441     DOI: 10.1002/bies.202000286

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  16 in total

1.  Topoisomerase VI is a chirally-selective, preferential DNA decatenase.

Authors:  Shannon J McKie; Parth Rakesh Desai; Yeonee Seol; Adam Mb Allen; Anthony Maxwell; Keir C Neuman
Journal:  Elife       Date:  2022-01-25       Impact factor: 8.140

2.  De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region.

Authors:  Kyle M Orritt; Lipeng Feng; Juliette F Newell; Jack N Sutton; Scott Grossman; Thomas Germe; Lauren R Abbott; Holly L Jackson; Benjamin K L Bury; Anthony Maxwell; Martin J McPhillie; Colin W G Fishwick
Journal:  RSC Med Chem       Date:  2022-06-16

Review 3.  A tale of topoisomerases and the knotty genetic material in the backdrop of Plasmodium biology.

Authors:  Priyanka Singh; Khushboo Rani; Akanksha Gotmare; Sunanda Bhattacharyya
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

4.  Topoisomerase Assays.

Authors:  John L Nitiss; Kostantin Kiianitsa; Yilun Sun; Karin C Nitiss; Nancy Maizels
Journal:  Curr Protoc       Date:  2021-10

Review 5.  Unravelling the mechanisms of Type 1A topoisomerases using single-molecule approaches.

Authors:  Dian Spakman; Julia A M Bakx; Andreas S Biebricher; Erwin J G Peterman; Gijs J L Wuite; Graeme A King
Journal:  Nucleic Acids Res       Date:  2021-06-04       Impact factor: 16.971

6.  Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.

Authors:  Dereje Abate Negatu; Andreas Beuchel; Abdeldjalil Madani; Nadine Alvarez; Chao Chen; Wassihun Wedajo Aragaw; Matthew D Zimmerman; Benoît Laleu; Martin Gengenbacher; Véronique Dartois; Peter Imming; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

Review 7.  What makes a type IIA topoisomerase a gyrase or a Topo IV?

Authors:  Jana Hirsch; Dagmar Klostermeier
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

8.  The hyperthermophilic archaeon Thermococcus kodakarensis is resistant to pervasive negative supercoiling activity of DNA gyrase.

Authors:  Paul Villain; Violette da Cunha; Etienne Villain; Patrick Forterre; Jacques Oberto; Ryan Catchpole; Tamara Basta
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

9.  Virtual screening, optimization and molecular dynamics analyses highlighting a pyrrolo[1,2-a]quinazoline derivative as a potential inhibitor of DNA gyrase B of Mycobacterium tuberculosis.

Authors:  Juan Marcelo Carpio Arévalo; Juliana Carolina Amorim
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

10.  A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.

Authors:  Uday S Ganapathy; Rubén González Del Río; Mónica Cacho-Izquierdo; Fátima Ortega; Joël Lelièvre; David Barros-Aguirre; Wassihun Wedajo Aragaw; Matthew D Zimmerman; Marissa Lindman; Véronique Dartois; Martin Gengenbacher; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.